Oscar Health (OSCR) EBIT Margin (2020 - 2025)
Oscar Health (OSCR) has disclosed EBIT Margin for 6 consecutive years, with 8.27% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIT Margin rose 1194.0% year-over-year to 8.27%, compared with a TTM value of 1.73% through Dec 2025, up 110.0%, and an annual FY2025 reading of 1.73%, up 110.0% over the prior year.
- EBIT Margin was 8.27% for Q4 2025 at Oscar Health, up from 4.17% in the prior quarter.
- Across five years, EBIT Margin topped out at 448.33% in Q1 2021 and bottomed at 20467.71% in Q2 2021.
- Average EBIT Margin over 5 years is 1690.02%, with a median of 0.43% recorded in 2022.
- The sharpest move saw EBIT Margin crashed -2043358bps in 2021, then soared 2046795bps in 2022.
- Year by year, EBIT Margin stood at 15.95% in 2021, then tumbled by -185bps to 13.6% in 2022, then skyrocketed by 157bps to 7.78% in 2023, then tumbled by -147bps to 3.67% in 2024, then skyrocketed by 325bps to 8.27% in 2025.
- Business Quant data shows EBIT Margin for OSCR at 8.27% in Q4 2025, 4.17% in Q3 2025, and 1.93% in Q2 2025.